Cargando…
State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid p...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193454/ https://www.ncbi.nlm.nih.gov/pubmed/10137796 |
_version_ | 1782338978574237696 |
---|---|
author | Adams, E. Kathleen Kreling, David H. Gondek, Kathleen |
author_facet | Adams, E. Kathleen Kreling, David H. Gondek, Kathleen |
author_sort | Adams, E. Kathleen |
collection | PubMed |
description | Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid payments to pharmacies. In this study, several data sources were used to develop 1991 estimates of average pharmacy ingredient and dispensing costs. A simulation was used to estimate the amounts States pay. Nationally, simulated payments averaged 96 percent of estimated costs overall but were lower for dispensing costs (79 percent) and higher for ingredient costs (102 percent). |
format | Online Article Text |
id | pubmed-4193454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
record_format | MEDLINE/PubMed |
spelling | pubmed-41934542014-11-04 State Medicaid Pharmacy Payments and Their Relation to Estimated Costs Adams, E. Kathleen Kreling, David H. Gondek, Kathleen Health Care Financ Rev Prescription Drugs: Payment and Policy Issues Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid payments to pharmacies. In this study, several data sources were used to develop 1991 estimates of average pharmacy ingredient and dispensing costs. A simulation was used to estimate the amounts States pay. Nationally, simulated payments averaged 96 percent of estimated costs overall but were lower for dispensing costs (79 percent) and higher for ingredient costs (102 percent). CENTERS for MEDICARE & MEDICAID SERVICES 1994 /pmc/articles/PMC4193454/ /pubmed/10137796 Text en |
spellingShingle | Prescription Drugs: Payment and Policy Issues Adams, E. Kathleen Kreling, David H. Gondek, Kathleen State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title | State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title_full | State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title_fullStr | State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title_full_unstemmed | State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title_short | State Medicaid Pharmacy Payments and Their Relation to Estimated Costs |
title_sort | state medicaid pharmacy payments and their relation to estimated costs |
topic | Prescription Drugs: Payment and Policy Issues |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193454/ https://www.ncbi.nlm.nih.gov/pubmed/10137796 |
work_keys_str_mv | AT adamsekathleen statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts AT krelingdavidh statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts AT gondekkathleen statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts |